These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18351014)

  • 1. Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease.
    Borlongan CV; Thanos CG; Skinner SJ; Geaney M; Emerich DF
    Cell Transplant; 2008; 16(10):987-92. PubMed ID: 18351014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplants of Encapsulated Rat Choroid Plexus Cells Exert Neuroprotection in a Rodent Model of Huntington's Disease.
    Borlongan CV; Thanos CG; Skinner SJM; Geaney M; Emerich DF
    Cell Transplant; 2007 Nov; 16(10):987-992. PubMed ID: 28866919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys.
    Emerich DF; Thanos CG; Goddard M; Skinner SJ; Geany MS; Bell WJ; Bintz B; Schneider P; Chu Y; Babu RS; Borlongan CV; Boekelheide K; Hall S; Bryant B; Kordower JH
    Neurobiol Dis; 2006 Aug; 23(2):471-80. PubMed ID: 16777422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington's disease.
    Borlongan CV; Skinner SJ; Geaney M; Vasconcellos AV; Elliott RB; Emerich DF
    Neuroreport; 2004 Nov; 15(16):2521-5. PubMed ID: 15538187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro culture duration does not impact the ability of encapsulated choroid plexus transplants to prevent neurological deficits in an excitotoxin-lesioned rat model of Huntington's disease.
    Emerich DF; Thanos CG
    Cell Transplant; 2006; 15(7):595-602. PubMed ID: 17176611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
    Vazey EM; Chen K; Hughes SM; Connor B
    Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
    Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
    Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
    Emerich DF; Bruhn S; Chu Y; Kordower JH
    Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum.
    Emerich DF; Hammang JP; Baetge EE; Winn SR
    Exp Neurol; 1994 Nov; 130(1):141-50. PubMed ID: 7821389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging reduces the neuroprotective capacity, VEGF secretion, and metabolic activity of rat choroid plexus epithelial cells.
    Emerich DF; Schneider P; Bintz B; Hudak J; Thanos CG
    Cell Transplant; 2007; 16(7):697-705. PubMed ID: 18019359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
    Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
    Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.
    McBride JL; Behrstock SP; Chen EY; Jakel RJ; Siegel I; Svendsen CN; Kordower JH
    J Comp Neurol; 2004 Jul; 475(2):211-9. PubMed ID: 15211462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
    Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
    Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
    Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease.
    Emerich DF; Lindner MD; Winn SR; Chen EY; Frydel BR; Kordower JH
    J Neurosci; 1996 Aug; 16(16):5168-81. PubMed ID: 8756445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.
    Ryu JK; Kim J; Cho SJ; Hatori K; Nagai A; Choi HB; Lee MC; McLarnon JG; Kim SU
    Neurobiol Dis; 2004 Jun; 16(1):68-77. PubMed ID: 15207263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.